brain arteriovenous malformation, hereditary hemorrhagic telangiectacia
Conditions
Interventions
None listed
Sponsors
Keio University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Diagnosis of brain arteriovenous malformation has been obtained through cerebral angiography, CT angiography, and MRI. 2 Gamma Knife treatment has been performed for the brain arteriovenous malformation between January 1, 2003, and May 30, 2021. 3 The medical history or diagnosis includes "multiple brain arteriovenous malformations," "Osler's disease," "HHT (hereditary hemorrhagic telangiectasia)," "hereditary hemorrhagic telangiectasia," and "hereditary peripheral telangiectasia."
Exclusion criteria
Exclusion criteria: 1 Patients with insufficient medical information. 2 Patients deemed unsuitable for conducting this investigation by the principal investigator or research collaborators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy : Occlusion status of brain arteriovenous malformations, timing of occlusion, rate of bleeding, rate of retreatment. adverse events: Symptomatic and asymptomatic events, seizures, neurological symptoms." | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging changes: Cerebral edema (extent, time to resolution), cyst formation, and others." | — |
Countries
Japan
Contacts
Public ContactTakenori Akiyama
Keio University, school of medicine Department of Neurosurgery
Outcome results
None listed